MedTrace Logo

PRIME: Cognitive Outcome Following Major Burns

NCT03242395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-08-08

No results posted yet for this study

Summary

PRIME aims to demonstrate through neurocognitive assessment that BICU patients will have a degree of neurocognitive dysfunction following a major burn, that this neurocognitive dysfunction is due to an underlying neuroinflammatory process by fMRI neuroimaging techniques, and that the neurocognitive deficit is associated with a reduced quality of life.

Conditions

Sponsors & Collaborators

  • University of Westminster

    collaborator OTHER

  • Imperial College Healthcare NHS Trust

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Chelsea and Westminster NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Marcela P Vizcaychipi, MD PhD · Anaesthetic and Intensive Care Consultant

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-02-28
Completion
2017-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242395 on ClinicalTrials.gov